ArticleInternational journal of molecular sciences2025

Blood-Based Inflammatory Markers Are Associated with Treatment Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Anti-PD-1 Therapy: CRP as a Superior Predictive Marker.

Manuel Stöth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.